Literature DB >> 21811526

Inpatient Oral Anticoagulation Management by Clinical Pharmacists: Safety and Cost effectiveness.

Sharath R Hosmane1, Johanna Tucker, Dave Osman, Steve Williams, Paul Waterworth.   

Abstract

BACKGROUND: Warfarin prescription for anticoagulation after cardiac surgery has always been a challenge for junior medical staff.
METHODS: A prospective study was carried out to assess the quality of anticoagulation control by junior doctors compared with clinical pharmacists at South Manchester University hospitals NHS Trust. The junior medical staff prescribed warfarin for 50 consecutive patients from April to September 2006 (group A, n = 50) and experienced clinical pharmacists dosed 46 consecutive patients between February and May 2007 (group B, n = 46).
RESULTS: In group A, 9 (18%) patients discharge was delayed because of lack of attainment of therapeutic International Normalised Ratio (INR) compared to 3 (6.5%) in group B. The total number of bed days resulting from the delay in group A was 21 compared to 4 in group B. Extrapolated over a year this would amount to approximately 15,750 extra cost incurred in group A opposed to 3000 in group B.
CONCLUSIONS: The pharmacists were significantly better than junior doctors in achieving therapeutic INR, resulting in fewer discharge delays. The clinical pharmacists with experience in outpatient anticoagulation clinic can play an important role in inpatient oral anticoagulation management in post cardiac surgery patients thereby providing improved cost effective quality of care. KEYWORDS: Warfarin; Pharmacist; Management.

Entities:  

Year:  2010        PMID: 21811526      PMCID: PMC3140885          DOI: 10.4021/jocmr2010.03.283w

Source DB:  PubMed          Journal:  J Clin Med Res        ISSN: 1918-3003


  8 in total

1.  Development and implementation of a pharmacist-managed inpatient warfarin protocol.

Authors:  David L Damaske; Robert W Baird
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-10

2.  Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy.

Authors:  Daniel M Witt; Melanie A Sadler; Roberta L Shanahan; Georgann Mazzoli; Donald J Tillman
Journal:  Chest       Date:  2005-05       Impact factor: 9.410

3.  Reduction in warfarin adverse events requiring patient hospitalization after implementation of a pharmacist-managed anticoagulation service.

Authors:  Christy Locke; Susan L Ravnan; Rajul Patel; James A Uchizono
Journal:  Pharmacotherapy       Date:  2005-05       Impact factor: 4.705

Review 4.  Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions.

Authors:  C A Bond; Cynthia L Raehl
Journal:  Pharmacotherapy       Date:  2004-08       Impact factor: 4.705

5.  Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic.

Authors:  S M Garabedian-Ruffalo; D R Gray; M J Sax; R L Ruffalo
Journal:  Am J Hosp Pharm       Date:  1985-02

6.  Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs.

Authors:  E Chiquette; M G Amato; H I Bussey
Journal:  Arch Intern Med       Date:  1998 Aug 10-24

Review 7.  Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention.

Authors:  C S Landefeld; R J Beyth
Journal:  Am J Med       Date:  1993-09       Impact factor: 4.965

8.  Outcome analysis of a pharmacist-managed anticoagulation service.

Authors:  V M Wilt; J G Gums; O I Ahmed; L M Moore
Journal:  Pharmacotherapy       Date:  1995 Nov-Dec       Impact factor: 4.705

  8 in total
  1 in total

Review 1.  Clinical impact of a pharmacist-led inpatient anticoagulation service: a review of the literature.

Authors:  Tiffany Lee; Erin Davis; Jason Kielly
Journal:  Integr Pharm Res Pract       Date:  2016-05-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.